ZKBio Access IVS Vulnerability: Remote Cross-Site Scripting Attack
CVE-2024-1706

5.1MEDIUM

Key Information:

Vendor

Zkteco

Status
Zkbio Access Ivs
Vendor
CVE Published:
21 February 2024

Badges

👾 Exploit Exists🟡 Public PoC

What is CVE-2024-1706?

A vulnerability was determined in ZKTeco ZKBio Access IVS up to 3.3.2. This impacts an unknown function of the component Department Name Search Bar. This manipulation with the input hi causes cross site scripting. Remote exploitation of the attack is possible. The exploit has been publicly disclosed and may be utilized. The vendor explains: "ZKBio Access IVS is no longer maintained and the product has been replaced by ZKBio CVAccess, it is recommended to replace it with the latest version of ZKBio CVAccess." This vulnerability only affects products that are no longer supported by the maintainer.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

ZKBio Access IVS 3.3.0

ZKBio Access IVS 3.3.1

ZKBio Access IVS 3.3.2

Exploit Proof of Concept (PoC)

PoC code is written by security researchers to demonstrate the vulnerability can be exploited. PoC code is also a key component for weaponization which could lead to ransomware.

CVE-2024-1706 - Proof of Concept

References

https://vuldb.com/?id.254396
vdb-entrytechnical-description
https://vuldb.com/?ctiid.254396
signaturepermissions-required
https://vuldb.com/?submit.280083
third-party-advisory

CVSS V4

Score:
5.1
Severity:
MEDIUM
Confidentiality:
None
Integrity:
Low
Availability:
None
Attack Vector:
Network
Attack Complexity:
Low
Attack Required:
None
Privileges Required:
Undefined
User Interaction:
Unknown

Timeline

  • 🟡

    Public PoC available

  • 👾

    Exploit known to exist

  • Vulnerability published

  • Vulnerability Reserved

Credit

Hussein Amer (VulDB User)
JSON
.